Literature DB >> 23345133

Oligodendrocyte N-methyl-D-aspartate receptor signaling: insights into its functions.

Nian Cao1, Zhong-Xiang Yao.   

Abstract

Myelination by oligodendrocytes facilitates rapid nerve conduction. Loss of oligodendrocytes and failure of myelination lead to nerve degeneration and numerous demyelinating white matter diseases. N-methyl-D-aspartate (NMDA) receptors, which are key regulators on neuron survival and functions, have been recently identified to express in oligodendrocytes, especially in the myelin sheath. NMDA receptor signaling in oligodendrocytes plays crucial roles in energy metabolism and myelination. In the present review, we highlight the subcellular location-specific impairment of excessive NMDA receptor signaling on oligodendrocyte energy metabolism in soma and myelin, and the mechanisms including Ca(2+) overload, acidotoxicity, mitochondria dysfunction, and impairment of respiratory chains. Conversely, physiological NMDA receptor signaling regulates differentiation and migration of oligodendrocytes. How can we use above knowledge to treat excitotoxic oligodendrocyte loss, congenital myelination deficiency, or postnatal demyelination? A thorough understanding of NMDA receptor signaling-mediated cellular events in oligodendrocytes at the pathophysiological level will no doubt aid in exploring effective therapeutic strategies for demyelinating white matter diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23345133     DOI: 10.1007/s12035-013-8408-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  143 in total

1.  Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors.

Authors:  E Meddows; B Le Bourdelles; S Grimwood; K Wafford; S Sandhu; P Whiting; R A McIlhinney
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

Review 2.  NMDA receptor subunits: diversity, development and disease.

Authors:  S Cull-Candy; S Brickley; M Farrant
Journal:  Curr Opin Neurobiol       Date:  2001-06       Impact factor: 6.627

Review 3.  Voltage-gated potassium channels in cell proliferation.

Authors:  Luis A Pardo
Journal:  Physiology (Bethesda)       Date:  2004-10

Review 4.  The glutamate receptor ion channels.

Authors:  R Dingledine; K Borges; D Bowie; S F Traynelis
Journal:  Pharmacol Rev       Date:  1999-03       Impact factor: 25.468

5.  Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity.

Authors:  Ruslan I Stanika; Natalia B Pivovarova; Christine A Brantner; Charlotte A Watts; Christine A Winters; S Brian Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

Review 6.  Matching mitochondria to metabolic needs at nodes of Ranvier.

Authors:  Shing Y Chiu
Journal:  Neuroscientist       Date:  2011-04-25       Impact factor: 7.519

7.  Regulation of Kv1 subunit expression in oligodendrocyte progenitor cells and their role in G1/S phase progression of the cell cycle.

Authors:  R Chittajallu; Y Chen; H Wang; X Yuan; C A Ghiani; T Heckman; C J McBain; V Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 8.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

9.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain.

Authors:  R P Simon; J H Swan; T Griffiths; B S Meldrum
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

Review 10.  Roles of white matter in central nervous system pathophysiologies.

Authors:  Carlos Matute; Bruce R Ransom
Journal:  ASN Neuro       Date:  2012-03-22       Impact factor: 4.146

View more
  7 in total

Review 1.  Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?

Authors:  P Steullet; J H Cabungcal; A Monin; D Dwir; P O'Donnell; M Cuenod; K Q Do
Journal:  Schizophr Res       Date:  2014-07-05       Impact factor: 4.939

2.  Linking proteomic alterations in schizophrenia hippocampus to NMDAr hypofunction in human neurons and oligodendrocytes.

Authors:  Giuliana S Zuccoli; Guilherme Reis-de-Oliveira; Bruna Garbes; Peter Falkai; Andrea Schmitt; Helder I Nakaya; Daniel Martins-de-Souza
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-10       Impact factor: 5.270

3.  In vivo spatiotemporal patterns of oligodendrocyte and myelin damage at the neural electrode interface.

Authors:  Keying Chen; Steven M Wellman; Yalikun Yaxiaer; James R Eles; Takashi Dy Kozai
Journal:  Biomaterials       Date:  2020-11-23       Impact factor: 12.479

Review 4.  Caught in vicious circles: a perspective on dynamic feed-forward loops driving oxidative stress in schizophrenia.

Authors:  Michel Cuenod; Pascal Steullet; Jan-Harry Cabungcal; Daniella Dwir; Ines Khadimallah; Paul Klauser; Philippe Conus; Kim Q Do
Journal:  Mol Psychiatry       Date:  2021-11-10       Impact factor: 13.437

5.  D-Aspartate treatment attenuates myelin damage and stimulates myelin repair.

Authors:  Valeria de Rosa; Agnese Secondo; Anna Pannaccione; Roselia Ciccone; Luigi Formisano; Natascia Guida; Roberta Crispino; Annalisa Fico; Roman Polishchuk; Antimo D'Aniello; Lucio Annunziato; Francesca Boscia
Journal:  EMBO Mol Med       Date:  2019-01       Impact factor: 12.137

6.  Src Family Kinases Inhibition Ameliorates Hypoxic-Ischemic Brain Injury in Immature Rats.

Authors:  Han Qiu; Tianyang Qian; Tong Wu; Ting Gao; Qinghe Xing; Laishuan Wang
Journal:  Front Cell Neurosci       Date:  2021-12-21       Impact factor: 5.505

7.  Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes.

Authors:  Juliana S Cassoli; Keiko Iwata; Johann Steiner; Paul C Guest; Christoph W Turck; Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  Front Cell Neurosci       Date:  2016-03-03       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.